Literature DB >> 23407174

Anti-atherosclerosis or No Anti-atherosclerosis: That is the miR-33 question.

Anders M Näär.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23407174      PMCID： PMC3880779          DOI： 10.1161/ATVBAHA.112.301021

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  15 in total

1.  miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling.

Authors:  Alberto Dávalos; Leigh Goedeke; Peter Smibert; Cristina M Ramírez; Nikhil P Warrier; Ursula Andreo; Daniel Cirera-Salinas; Katey Rayner; Uthra Suresh; José Carlos Pastor-Pareja; Enric Esplugues; Edward A Fisher; Luiz O F Penalva; Kathryn J Moore; Yajaira Suárez; Eric C Lai; Carlos Fernández-Hernando
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-16       Impact factor: 11.205

2.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

Authors:  Katey J Rayner; Frederick J Sheedy; Christine C Esau; Farah N Hussain; Ryan E Temel; Saj Parathath; Janine M van Gils; Alistair J Rayner; Aaron N Chang; Yajaira Suarez; Carlos Fernandez-Hernando; Edward A Fisher; Kathryn J Moore
Journal:  J Clin Invest       Date:  2011-06-06       Impact factor: 14.808

3.  Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation.

Authors:  Isabelle Gerin; Laure-Alix Clerbaux; Olivier Haumont; Nicolas Lanthier; Arun K Das; Charles F Burant; Isabelle A Leclercq; Ormond A MacDougald; Guido T Bommer
Journal:  J Biol Chem       Date:  2010-08-22       Impact factor: 5.157

4.  miR-33 links SREBP-2 induction to repression of sterol transporters.

Authors:  Tyler J Marquart; Ryan M Allen; Daniel S Ory; Angel Baldán
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

5.  MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis.

Authors:  S Hani Najafi-Shoushtari; Fjoralba Kristo; Yingxia Li; Toshi Shioda; David E Cohen; Robert E Gerszten; Anders M Näär
Journal:  Science       Date:  2010-05-13       Impact factor: 47.728

6.  MiR-33 contributes to the regulation of cholesterol homeostasis.

Authors:  Katey J Rayner; Yajaira Suárez; Alberto Dávalos; Saj Parathath; Michael L Fitzgerald; Norimasa Tamehiro; Edward A Fisher; Kathryn J Moore; Carlos Fernández-Hernando
Journal:  Science       Date:  2010-05-13       Impact factor: 47.728

7.  MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo.

Authors:  Takahiro Horie; Koh Ono; Masahito Horiguchi; Hitoo Nishi; Tomoyuki Nakamura; Kazuya Nagao; Minako Kinoshita; Yasuhide Kuwabara; Hiroyuki Marusawa; Yoshitaka Iwanaga; Koji Hasegawa; Masayuki Yokode; Takeshi Kimura; Toru Kita
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-20       Impact factor: 11.205

8.  Medicine. HDL miR-ed down by SREBP introns.

Authors:  Michael S Brown; Jin Ye; Joseph L Goldstein
Journal:  Science       Date:  2010-06-18       Impact factor: 47.728

Review 9.  ABCA1: at the nexus of cholesterol, HDL and atherosclerosis.

Authors:  Alan D Attie
Journal:  Trends Biochem Sci       Date:  2007-02-26       Impact factor: 13.807

10.  Anti-miR-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice.

Authors:  Tyler J Marquart; Judy Wu; Aldons J Lusis; Ángel Baldán
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311
View more
  8 in total

1.  MicroRNA-management of lipoprotein homeostasis.

Authors:  Xinghui Sun; Mark W Feinberg
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

Review 2.  MicroRNA: a connecting road between apoptosis and cholesterol metabolism.

Authors:  Yogita K Adlakha; Neeru Saini
Journal:  Tumour Biol       Date:  2016-04-22

Review 3.  Atherosclerosis.

Authors:  Hong Lu; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03       Impact factor: 8.311

Review 4.  MicroRNAs in the Pathobiology and Therapy of Atherosclerosis.

Authors:  Benoit Laffont; Katey J Rayner
Journal:  Can J Cardiol       Date:  2017-01-05       Impact factor: 5.223

Review 5.  Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP.

Authors:  Xu Xu; Jae-Seon So; Jong-Gil Park; Ann-Hwee Lee
Journal:  Semin Liver Dis       Date:  2013-11-12       Impact factor: 6.115

Review 6.  Fibroblast growth factor 21 potentially inhibits microRNA-33 expression to affect macrophage actions.

Authors:  Yuan Guo; Fei Luo; Yuhong Yi; Danyan Xu
Journal:  Lipids Health Dis       Date:  2016-12-01       Impact factor: 3.876

7.  MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice.

Authors:  Takahiro Horie; Tomohiro Nishino; Osamu Baba; Yasuhide Kuwabara; Tetsushi Nakao; Masataka Nishiga; Shunsuke Usami; Masayasu Izuhara; Naoya Sowa; Naoya Yahagi; Hitoshi Shimano; Shigenobu Matsumura; Kazuo Inoue; Hiroyuki Marusawa; Tomoyuki Nakamura; Koji Hasegawa; Noriaki Kume; Masayuki Yokode; Toru Kita; Takeshi Kimura; Koh Ono
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

8.  Soy and fish as features of the Japanese diet and cardiovascular disease risks.

Authors:  Yukio Yamori; Miki Sagara; Yoshimi Arai; Hitomi Kobayashi; Kazumi Kishimoto; Ikuko Matsuno; Hideki Mori; Mari Mori
Journal:  PLoS One       Date:  2017-04-21       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.